• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

Scale FinanceScale Finance Logo, Interim CFO, Part Time CFO Services, Accounting Support, Temporary CFO, Accounting Bookkeeping Services

Interim CFO, Part Time CFO Services, Accounting Support, Temporary CFO, Accounting Bookkeeping Services

Charlotte · Raleigh – Durham · Chapel Hill · Triad · Southern Pines · Coastal Carolina
Closing the GAAP to Scale Your Business
The FINACA Logo
919-230-4667
Scale Finance, LLC, Financing, North Myrtle Beach, SC
  • Home
  • Services
    • CFO & Controller Services
    • Capital Raise Services
    • Business Valuations
    • Mergers & Acquisitions
    • Professional Consultations at No Cost
  • Professionals
    • Partners
    • Charlotte Team
    • Raleigh – Durham – Chapel Hill Team
    • Greensboro-Southern Pines
    • Coastal Carolina Team
  • Client Experience
    • Closed Capital Raise Transactions
    • Closed M&A Transactions
    • Client Endorsements
    • Information Technology
    • Healthcare, Biopharma & Medical Device
    • Services, Energy, Industrial
    • Consumer, Retail, Media
    • Real Estate
    • Private Equity Groups
  • Recent News
  • Knowledge Bank
    • Best Practices in Scaling Companies
    • Entrepreneurial Management Skill- Building
    • Financial Management
    • Mergers & Acquisitions
    • Regulatory Developments
    • Venture Capital
  • Contact Us
    • Charlotte
    • Raleigh – Durham – Chapel Hill
    • Triad – Southern Pines
    • Coastal Carolina
  • Joining Our Firm

NC Biotech Center Expanding Financing Capacity

Source: Rick Smith, WRAL Local TechWire Editor

Despite cuts in its own state funding, the North Carolina Biotechnology Center is doubling the size of loans it makes to early-stage life science companies. Why?

Lack of private-sector capital, says Peter Ginsberg, the Center’s vice president for business and technology development.

“In fact, in many cases, an NCBiotech loan is the first outside funding into a company at a time when no other funding is available given the dearth of early-stage funding options for life science companies,” he explains.

The maximum amount available has been increased to $500,000, the Center disclosed last month.

In an exclusive Q&A interview for WRAL TechWire Insiders, Ginsberg answers in detail a series of questions about the “SGL,” or Strategic Growth Loan, program which the Center has used for years to help jumpstart new and emerging life science companies across the state. North Carolina has one of the nation’s largest life science technology “clusters,” which is responsible for an estimated 237,000 jobs and produces an economic impact of $59 billion a year, according to Biotech Center statistics.

More than 200 companies have received some $22 million in loans. Current loans are repaid with interest plus 3 percent above the prime rate, according to the Center. There are at present 74 companies in the Center’s “loan portfolio.” Companies must meet a variety of credit-related criteria such as being able to secure an investor match. The Center also awards grants for a variety of programs and research.

The N.C. General Assembly and Gov. Pat McCrory cut Biotech Center funding nearly 27 percent for fiscal 2014, leading to job cuts and program reductions. But long-time CEO Norris Tolson, who retired effective June 30, and Center leadership resolved to expand, not cut, the SGL funding.

Recent venture capital statistics show that while institutional VC funding has soared nationally back to “dot com” era highs, in North Carolina the opposite is true. Funding has dropped despite a number of life science companies going public over the past 18 months.

WRAL TechWire’s Q&A with Ginsberg:

  • What are the reasons why the Biotech Center decided to increase the cap for SGL loans?

Our primary goal with this increase is to further help NC-based life science companies bridge the early-stage funding gap that exists between the time of company start-up to when it can attract major institutional investor and/or strategic partner funding. The larger loan is expected to catalyze additional company growth and job creation beyond the Center’s funding and programmatic activities already in place.

  • Are companies needing more money and if so why?

Yes, the cost of developing drugs and other life science products has continued to increase. At the same time, many VCs have increasingly focused their investments on later-stage companies, thereby widening the early-stage funding gap noted above.

  • Is an overall lack of funding from investors contributing to the need for a larger cap?

While we have experienced VCs in the area, we believe that the amount of capital available locally is far exceeded by the capital required to fund the promising products and technologies coming out of North Carolina’s start-ups and universities. To ensure that more of these promising products and technologies advance toward commercialization, NCBiotech provides loans to companies. The goal is to allow companies to create value at an early stage of technology development that is recognized by VCs and other technology investors for further investment.

  • Given that the GA has cut the Biotech Center’s budget, where is the capital coming from to support larger loans? Is this a separate fund?

When NCBiotech restructured following the budget reduction announced last summer, we indicated that we would prioritize those programs that generated the strongest success metrics. Our loan program remains one of NCBiotech’s critical programs since it has been able to avoid most of the bad credit loan fiasco and since it has consistently had a major impact on the growth of the state’s life science industry.

In fact, in many cases, an NCBiotech loan is the first outside funding into a company at a time when no other funding is available given the dearth of early-stage funding options for life science companies.

  • How many loans or how much funding (or both) does the Biotech Center make available each year?

The Center awarded 21 loans in our fiscal 2014, which ended in June. Our loans now range in size from $50,000 to $500,000.

  • Who at the Biotech Center determines the credit worthiness and/or potential of companies that apply?

NCBiotech’s loan evaluation team includes members with deep business, technical and investment experience having held previous positions in the life science industry, academic and financial communities. All loan applications undergo a formal technical and business evaluation process that often includes external reviews by subject experts.

 

About Scale Finance

Scale Finance LLC (www.scalefinance.com) provides contract CFO services, Controller solutions, and support in raising capital, or executing M&A transactions, to entrepreneurial companies. The firm specializes in cost-effective financial reporting, budgeting & forecasting, implementing controls, complex modeling, business valuations, and other financial management, and provides strategic help for companies raising growth capital or considering M&A/recapitalization opportunities. Most of the firm’s clients are growing technology, healthcare, business services, consumer, and industrial companies at various stages of development from start-up to tens of millions in annual revenue. Scale Finance LLC has offices throughout the southeast including Charlotte, Raleigh/Durham, Greensboro, Wilmington, Washington D.C. and South Florida with a team of more than 40 professionals serving more than 100 companies throughout the region.

Primary Sidebar

Knowledge Bank

Mitigating Risk for Small Companies – How to Best Leverage Your Attorney

How Small Companies Are Experimenting with Cryptocurrency Applications – Cardano Example

Hiring a Startup CFO – When to Hire a CFO & Why You Need One

Owner Financing of Small Companies – Debt or Equity Considerations

Will Your Merger be Blindsided by Fraud?

Series C & Beyond: How Growth Investing is Different Than Early Stage

5 Rules for an A+ Board Meeting for Investor-backed Companies

Understanding & Using Your Cash Flow Statement

Why Business Valuations are Helpful (& What do they Typically Cost)?

Managing Merchant Fees – Role of Zero Fee Processing

Can Accountants Value a Business?

Personal Guarantees – Should You Grant One?

10 Pieces of Advice When Someone Wants to Buy Your Company

Convertible Note Financing – Payback Time

Due Diligence Fiasco – A Look Back at HP-Autonomy

Applying for Business Loans – Hard Credit Checks

7 Ways a Business Name Generator Can Help Entrepreneurs

Citizenship by Investment Overview

Understanding the True Cost of Employee Turnover

How to Think About Valuation When Raising Venture Capital

Explore the Knowledge Bank…

Secondary Sidebar

Recent News

Scale Finance Closes $20M ABL Financing for TRA

Scale Finance Leads the Successful Sale of Carolina Restoration Services

Scale Finance Advises FX HedgePool on $8M Series A Funding

SF Closes Acquisition of Midwest Outdoor Resorts for Travel Resorts of America

Scale Finance Closes $7 Million Senior Debt Financing for Travel Resorts of America

Scale Finance Advises on Acquisition of Falcone Crawl Space & Structural Repair

Congrats to Payzer for Closing $23 Million Equity Financing

SF Client Headbands of Hope Closes Strategic Growth Investment

SF Assists Semper Investment Company in Acquisition of ACM Removal

SF Client SentryOne Acquired by SolarWinds (NYSE: SWI)

Scale Finance Assists GPM with Acquisition by Netsmart

SF Client Broadstep Behavioral Health Continues National Growth Through Acquisitions

SF Client Impact Financial Systems (IFS) Acquired by iPipeline

Scale Finance Assists TrueLearn with Investment by LLR Partners

Scale Finance Assists Textum Weaving with Investment by Quad-C

Scale Finance Closes Debt Financing for Horizon Eye Care

Scale Finance Closes Acquisition of Horsepower Site Services by MCG Civil

More News…

Footer

Media

Scale Finance Managing Director Dave Gilroy interviewed on WSIC Radio (local Fox affiliate)

/wp-content/uploads/2014/02/David-Gilroy-Interview-Local-Biz-Now-2-7-14.mp3

Entrepreneurial Tips

  • Funding Tips from Scale Finance
  • CIE Life Sciences Panel Discussion
  • Why Use Fractional CFO Services

Sign Up—Finance Bulletin

Monthly insights into corporate finance for entrepreneurial companies

Sending

FINACA is a nationwide network of independent finance and accounting consulting firms focused on delivering exceptional client service.

FINACA is a nationwide network of independent finance and accounting consulting firms focused on delivering exceptional client service.

Return to top of page

Copyright © 2008–2023 Scale Finance, LLC
Securities and offering services through Charles Towne Securities, LLC. Members FINRA and SIPC.